{"nct_id":"NCT01605227","title":"Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100","status":"COMPLETED","status_verified_date":"2018-02","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2014-09","primary_completion_date_type":"ACTUAL","completion_date":"2015-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["EXEL"]}